{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:50:57Z","timestamp":1780527057118,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.metabol.2010.03.010","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T09:12:05Z","timestamp":1272445925000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients"],"prefix":"10.1016","volume":"60","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibilla A.T.","family":"Salvadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2010.03.010_bb0005","first-page":"468","article-title":"Interdisciplinary European guidelines on surgery for severe obesity","volume":"87","author":"Fried","year":"2008","journal-title":"Rozhl Chir"},{"issue":"4 Suppl 1","key":"10.1016\/j.metabol.2010.03.010_bb0010","first-page":"83S","article-title":"Pharmacological therapy of obesity","volume":"9","author":"Pagotto","year":"2008","journal-title":"G Ital Cardiol (Rome)"},{"key":"10.1016\/j.metabol.2010.03.010_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2298\/SARH0804122M","article-title":"Elevated body mass index fatty liver","volume":"136","author":"Marovi\u0107","year":"2008","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.metabol.2010.03.010_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3810\/pgm.2008.07.1788","article-title":"The obesity paradox: impact of obesity on the prevalence prognosis of cardiovascular diseases","volume":"120","author":"Lavie","year":"2008","journal-title":"Postgrad Med"},{"issue":"S1","key":"10.1016\/j.metabol.2010.03.010_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2337\/diacare.27.2007.S36","article-title":"Nutrition principles and recommendations in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.metabol.2010.03.010_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diacare.27.2007.S58","article-title":"Physical activity\/exercise and diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2010.03.010_bb0035","doi-asserted-by":"crossref","first-page":"68B","DOI":"10.1016\/j.amjcard.2006.11.007","article-title":"Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction","volume":"99","author":"Lee","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2010.03.010_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2010.03.010_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine: a review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.metabol.2010.03.010_bb0050","series-title":"Sibutramine, summary of product characteristic","author":"Abbott Laboratories limited","year":"2000"},{"key":"10.1016\/j.metabol.2010.03.010_bb0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880110708","article-title":"Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria","volume":"11","author":"Uziel","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.metabol.2010.03.010_bb0060","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0149-2918(03)80130-3","article-title":"The effect of l-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.metabol.2010.03.010_bb0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymgme.2008.02.002","article-title":"Cardiomyopathy carnitine deficiency","volume":"94","author":"Amat di San Filippo","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2010.03.010_bb0070","series-title":"Biochemistry for medical sciences","first-page":"318","author":"Newsholme","year":"1983"},{"key":"10.1016\/j.metabol.2010.03.010_bb0075","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2010.03.010_bb0080","series-title":"Report of WHO consultation on obesity","article-title":"Obesity: preventing and managing the global epidemic","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.metabol.2010.03.010_bb0085","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.ATV.0000238352.25222.5e","article-title":"Summary of American Heart Association diet and lifestyle recommendations revision 2006","volume":"26","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2010.03.010_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.635569","article-title":"The glycosylation of haemoglobin. Relevance to diabetes mellitus","volume":"200","author":"Bunn","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.metabol.2010.03.010_bb0095","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","article-title":"A desktop guide to type 2 diabetes mellitus","volume":"16","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF01225569","article-title":"Determination of total serum insulin (IRI) in insulin-treated diabetic patients","volume":"8","author":"Heding","year":"1972","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2010.03.010_bb0105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2010.03.010_bb0110","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2010.03.010_bb0115","first-page":"121","article-title":"Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II)","volume":"15","author":"Klose","year":"1978","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.metabol.2010.03.010_bb0120","series-title":"Methods of enzymatic analysis: triglycerides determination after enzymatic hydrolysis","first-page":"18","author":"Wahlefeld","year":"1974"},{"key":"10.1016\/j.metabol.2010.03.010_bb0125","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2010.03.010_bb0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2010.03.010_bb0135","first-page":"540","article-title":"Leptin: its receptor and obesity","volume":"44","author":"Misra","year":"1996","journal-title":"J Invest Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0140","series-title":"The cytokine handbook","author":"Zhang","year":"1988"},{"key":"10.1016\/j.metabol.2010.03.010_bb0145","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nature Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0150","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.metabol.2010.03.010_bb0155","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","article-title":"Clinical efficacy of an automated high-sensitivity C-reactive protein assay","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2010.03.010_bb0160","series-title":"Statistical principles in experimental design","author":"Winer","year":"1971"},{"key":"10.1016\/j.metabol.2010.03.010_bb0165","first-page":"247","article-title":"l-Carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)","volume":"10","author":"Sirtori","year":"2000","journal-title":"Nutr Metab Cardiovas Dis"},{"key":"10.1016\/j.metabol.2010.03.010_bb0170","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.metabol.2008.06.010","article-title":"Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone","volume":"57","author":"Derosa","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2010.03.010_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2169\/internalmedicine.48.1670","article-title":"Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine","volume":"48","author":"Derosa","year":"2009","journal-title":"Inter Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","article-title":"Obesity wars: molecular progress confronts an expanding epidemic","volume":"116","author":"Flier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2010.03.010_bb0185","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2010.03.010_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.metabol.2010.03.010_bb0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNF-alpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20050243","article-title":"Neuroendocrine and metabolic effects of adipocyte-derived hormones","volume":"110","author":"Jackson","year":"2006","journal-title":"Clinical Science"},{"key":"10.1016\/j.metabol.2010.03.010_bb0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","article-title":"ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism","volume":"13","author":"Berg","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2010.03.010_bb0210","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/sj.ijo.0802908","article-title":"Adiponectin: a relevant player in PPAR\u03b3-agonist\u2013mediated improvements in hepatic insulin sensitivity?","volume":"29","author":"Bouskila","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2010.03.010_bb0215","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0220","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2010.03.010_bb0225","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2010.03.010_bb0230","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2005.11.039","article-title":"Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes","volume":"339","author":"Kl\u00f6ting","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2010.03.010_bb0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1074\/mcp.M600217-MCP200","article-title":"Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis","volume":"6","author":"Zvonic","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2010.03.010_bb0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated lipoprotein uptake by macrophages","volume":"103","author":"Zwacka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2010.03.010_bb0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2004.00372.x","article-title":"Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients","volume":"7","author":"Derosa","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2010.03.010_bb0250","first-page":"222","article-title":"Comparison of metabolic effects of orlistat and sibutramine treatment in type 2 diabetic obese patients","volume":"17","author":"Derosa","year":"2004","journal-title":"Diabetes Nutr Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:53:24Z","timestamp":1758426804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049510001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0026049510001009"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2010.03.010","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2010.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}